BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11536250)

  • 1. Evidence for persistence of parvovirus B19 DNA in livers of adults.
    Eis-Hübinger AM; Reber U; Abdul-Nour T; Glatzel U; Lauschke H; Pütz U
    J Med Virol; 2001 Oct; 65(2):395-401. PubMed ID: 11536250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
    Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
    J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
    Cassinotti P; Siegl G; Michel BA; Brühlmann P
    J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow.
    Lundqvist A; Tolfvenstam T; Bostic J; Söderlund M; Broliden K
    Scand J Infect Dis; 1999; 31(1):11-6. PubMed ID: 10381211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvovirus B19 infection of bone marrow in systemic sclerosis patients.
    Ferri C; Zakrzewska K; Longombardo G; Giuggioli D; Storino FA; Pasero G; Azzi A
    Clin Exp Rheumatol; 1999; 17(6):718-20. PubMed ID: 10609071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders.
    Lundqvist A; Tolfvenstam T; Brytting M; Stolt CM; Hedman K; Broliden K
    Scand J Infect Dis; 1999; 31(2):119-22. PubMed ID: 10447317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
    Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The investigation of parvovirus B19 infection in patients with haematological disorders by using PCR and ELISA techniques.
    Us T; Ozune L; Kasifoglu N; Akgun Y
    Braz J Infect Dis; 2007 Jun; 11(3):327-30. PubMed ID: 17684634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Study of Parvovirus B19 Infection in Children with Acute Myeloid Leukemia.
    Tharwat Abou El-Khier N; Darwish A; El Sayed Zaki M
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):337-342. PubMed ID: 29479965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human parvovirus B19 in cancer patients using ELISA and real-time PCR.
    Zaki SA
    Indian J Med Microbiol; 2012; 30(4):407-10. PubMed ID: 23183464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
    van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
    Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW; Knöll A; Küster RM; Modrow S
    Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human parvovirus B19 infection: a study of 212 suspected cases in the state of Rio de Janeiro, Brazil.
    Wermelinger MC; Oelemann WM; Lima de Mendonça MC; Naveca FG; von Hubinger MG
    J Clin Virol; 2002 Aug; 25(2):223-30. PubMed ID: 12367658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
    Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
    Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
    Chen MY; Lee KL; Hung CC
    J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
    Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
    J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
    Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
    J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients.
    Obeid OE
    J Infect Dev Ctries; 2011 Jul; 5(7):535-9. PubMed ID: 21795822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
    Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
    Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.